These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10102230)

  • 1. Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis.
    Connett GJ; Lucas JS; Atchley JT; Fairhurst JJ; Rolles CJ
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):181-3. PubMed ID: 10102230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis.
    Mac Sweeney EJ; Oades PJ; Buchdahl R; Rosenthal M; Bush A
    Lancet; 1995 Mar; 345(8952):752-6. PubMed ID: 7534369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis.
    Ramsden WH; Moya EF; Littlewood JM
    Arch Dis Child; 1998 Oct; 79(4):339-43. PubMed ID: 9875045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: colonic stricture and fibrosis associated with high-strength pancreatic enzymes in a child with cystic fibrosis.
    McHugh K; Thomson A; Tam P
    Br J Radiol; 1994 Sep; 67(801):900-1. PubMed ID: 7953234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis.
    Littlewood JM; Connett GJ; Sander-Struckmeier S; Henniges F;
    Expert Opin Drug Saf; 2011 Mar; 10(2):197-203. PubMed ID: 21342076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
    Smyth RL; Ashby D; O'Hea U; Burrows E; Lewis P; van Velzen D; Dodge JA
    Lancet; 1995 Nov; 346(8985):1247-51. PubMed ID: 7475715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colonic toxicity from pancreatins: a contemporary safety issue.
    Powell CJ
    Lancet; 1999 Mar; 353(9156):911-5. PubMed ID: 10093998
    [No Abstract]   [Full Text] [Related]  

  • 9. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.
    Smyth RL; van Velzen D; Smyth AR; Lloyd DA; Heaf DP
    Lancet; 1994 Jan; 343(8889):85-6. PubMed ID: 7903780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound studies of the intestinal wall in patients with cystic fibrosis.
    Pohl M; Krackhardt B; Posselt HG; Lembcke B
    J Pediatr Gastroenterol Nutr; 1997 Sep; 25(3):317-20. PubMed ID: 9285384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic changes in cystic fibrosis: clinical-ultrasonographic features and their value for treatment.
    Antonelli M; Matrunola M; Tontini A; Diamanti S
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):232. PubMed ID: 9675666
    [No Abstract]   [Full Text] [Related]  

  • 12. Colonic strictures in cystic fibrosis.
    Taylor CJ
    Lancet; 1994 Mar; 343(8898):615-6. PubMed ID: 7906805
    [No Abstract]   [Full Text] [Related]  

  • 13. Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States.
    Freiman JP; FitzSimmons SC
    J Pediatr Gastroenterol Nutr; 1996 Feb; 22(2):153-6. PubMed ID: 8642487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First adult patient with fibrosing colonopathy.
    Häusler M; Meilicke R; Biesterfeld S; Heimann G
    Am J Gastroenterol; 1998 Jul; 93(7):1171-2. PubMed ID: 9672356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonographic evaluation of bowel wall thickness in patients with cystic fibrosis.
    Dialer I; Hundt C; Bertele-Harms RM; Harms HK
    J Clin Gastroenterol; 2003 Jul; 37(1):55-60. PubMed ID: 12811210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.
    Haber HP; Benda N; Fitzke G; Lang A; Langenberg M; Riethmüller J; Stern M
    Gut; 1997 Mar; 40(3):406-11. PubMed ID: 9135533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.
    Waters BL
    Pediatr Dev Pathol; 1998; 1(1):74-8. PubMed ID: 10463274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
    Gan KH; Heijerman HG; Geus WP; Bakker W; Lamers CB
    Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosing colonopathy in children with cystic fibrosis.
    Reichard KW; Vinocur CD; Franco M; Crisci KL; Flick JA; Billmire DF; Schidlow DV; Weintraub WH
    J Pediatr Surg; 1997 Feb; 32(2):237-41; discussion 241-2. PubMed ID: 9044129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.